Chanjuan Zhang, Yadan Zheng, Guihua Jiang, Jing Luo, Liujie Su, Yinan Ai, Chenyang Feng, Chao Li, Shumei Li, Xiquan Hu
{"title":"Enhancement of glymphatic function and cognition in chronic insomnia using low-frequency rTMS.","authors":"Chanjuan Zhang, Yadan Zheng, Guihua Jiang, Jing Luo, Liujie Su, Yinan Ai, Chenyang Feng, Chao Li, Shumei Li, Xiquan Hu","doi":"10.1093/sleep/zsaf083","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objectives: </strong>Low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) is a promising treatment for chronic insomnia; however, its effectiveness in improving cognitive and glymphatic clearance functions remains unclear. We aimed to investigate the effects of chronic insomnia on glymphatic clearance function and the effectiveness of LF-rTMS on chronic insomnia.</p><p><strong>Methods: </strong>Thirty-two patients with chronic insomnia and 40 healthy controls underwent baseline assessments of clinical measures and glymphatic functions using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS). Thereafter, 22 patients underwent 10 sessions of LF-rTMS over two consecutive weeks, sleep assessments at week 2 and months 1, 2, and 3, and DTI-ALPS and cognitive-related assessments at week 2 and month 3.</p><p><strong>Results: </strong>Compared to healthy controls, patients showed significant differences in the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Montreal Cognitive Assessment (MoCA) Scale, digit symbol substitution test (DSST), color trail test (CTT), digit span test (DST), Stroop tests, and DTI-ALPS index (all ps < 0.05). After LF-rTMS, patients showed a significant decrease in PSQI and ISI scores from week 2 onwards and significant improvement in MoCA, DSST, DST, CTT-B tests, and DTI-ALPS index by month 3 (all ps < 0.05). Furthermore, the increase in the DTI-ALPS index was significantly associated with improvements in PSQI, ISI, MoCA, and DST-backward at month 3 (r = 0.579, 0.558, 0.836, and 0.642, respectively, and p = 0.038, 0.047, <0.001, and 0.018, respectively).</p><p><strong>Conclusions: </strong>This study provided preliminary evidence for LF-rTMS' valuable effects on glymphatic clearance and cognitive function in patients with chronic insomnia, which supports LF-rTMS' clinical application in those population.</p><p><strong>Clinical trial information: </strong>This study has been officially registered with the Chinese Clinical Trial Registry. The trial, titled \"Effect of Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Insomnia and the Underlying Brain Mechanism,\" is accessible via the following URL: https://www.chictr.org.cn/showproj.html?proj=205347. The registration number assigned to this trial is ChiCTR2300077939.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sleep/zsaf083","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Study objectives: Low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) is a promising treatment for chronic insomnia; however, its effectiveness in improving cognitive and glymphatic clearance functions remains unclear. We aimed to investigate the effects of chronic insomnia on glymphatic clearance function and the effectiveness of LF-rTMS on chronic insomnia.
Methods: Thirty-two patients with chronic insomnia and 40 healthy controls underwent baseline assessments of clinical measures and glymphatic functions using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS). Thereafter, 22 patients underwent 10 sessions of LF-rTMS over two consecutive weeks, sleep assessments at week 2 and months 1, 2, and 3, and DTI-ALPS and cognitive-related assessments at week 2 and month 3.
Results: Compared to healthy controls, patients showed significant differences in the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Montreal Cognitive Assessment (MoCA) Scale, digit symbol substitution test (DSST), color trail test (CTT), digit span test (DST), Stroop tests, and DTI-ALPS index (all ps < 0.05). After LF-rTMS, patients showed a significant decrease in PSQI and ISI scores from week 2 onwards and significant improvement in MoCA, DSST, DST, CTT-B tests, and DTI-ALPS index by month 3 (all ps < 0.05). Furthermore, the increase in the DTI-ALPS index was significantly associated with improvements in PSQI, ISI, MoCA, and DST-backward at month 3 (r = 0.579, 0.558, 0.836, and 0.642, respectively, and p = 0.038, 0.047, <0.001, and 0.018, respectively).
Conclusions: This study provided preliminary evidence for LF-rTMS' valuable effects on glymphatic clearance and cognitive function in patients with chronic insomnia, which supports LF-rTMS' clinical application in those population.
Clinical trial information: This study has been officially registered with the Chinese Clinical Trial Registry. The trial, titled "Effect of Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Insomnia and the Underlying Brain Mechanism," is accessible via the following URL: https://www.chictr.org.cn/showproj.html?proj=205347. The registration number assigned to this trial is ChiCTR2300077939.
期刊介绍:
SLEEP® publishes findings from studies conducted at any level of analysis, including:
Genes
Molecules
Cells
Physiology
Neural systems and circuits
Behavior and cognition
Self-report
SLEEP® publishes articles that use a wide variety of scientific approaches and address a broad range of topics. These may include, but are not limited to:
Basic and neuroscience studies of sleep and circadian mechanisms
In vitro and animal models of sleep, circadian rhythms, and human disorders
Pre-clinical human investigations, including the measurement and manipulation of sleep and circadian rhythms
Studies in clinical or population samples. These may address factors influencing sleep and circadian rhythms (e.g., development and aging, and social and environmental influences) and relationships between sleep, circadian rhythms, health, and disease
Clinical trials, epidemiology studies, implementation, and dissemination research.